Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy
You Ke,1 Cheng Xiang2 1Department of Nephrology, The Second Affiliated Hospital of Zhejiang University, Hangzhou, China; 2Department of Surgery, The Second Affiliated Hospital of Zhejiang University, Hangzhou, China Background: Thyroid cancer becomes the most common endocrine cancer with the great...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2018
|
| Subjects: | |
| Online Access: | https://doaj.org/article/982fc76b45f340d6a995fcae8a006fdd |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!